1887

Abstract

A matched nested case–control study of 33 paired cases and controls was conducted, based on a study cohort in Long An county, Guangxi, China, to determine whether infection with hepatitis B virus (HBV) with pre-S deletions is independently associated with the development of hepatocellular carcinoma (HCC), without the confounding effects of basal core promoter (BCP) double mutations. The prevalence of pre-S deletions was significantly higher in HCC (45.5 %, 15 of 33) than the controls (18.2 %, 6 of 33) (<0.01), under the control of the influence of BCP double mutations. Most of the pre-S deletions occurred in, or involved, the 5′ half of the pre-S2 region and the difference between HCC (93.3 %, 14 of 15) and controls (66.7 %, four of six) was significant for this region (=0.015). There was no significant difference in pre-S deletions between the BCP mutant group and BCP wild-type group (>0.05), nor was the prevalence of pre-S deletions significantly different between genotypes B and C (>0.1). These results suggest that pre-S deletions constitute an independent risk factor for HCC and their emergence and effect are independent of BCP mutations. The 5′ terminus of pre-S2 is the favoured site for the deletion mutations, especially in HCC cases. Further prospective studies are required to confirm the role of these mutations in the development of HCC.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.2008/002824-0
2008-11-01
2019-11-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/89/11/2882.html?itemId=/content/journal/jgv/10.1099/vir.0.2008/002824-0&mimeType=html&fmt=ahah

References

  1. Arauz-Ruiz, P., Norder, H., Robertson, B. H. & Magnius, L. O. ( 2002; ). Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 83, 2059–2073.
    [Google Scholar]
  2. Baptista, M., Kramvis, A. & Kew, M. C. ( 1999; ). High prevalence of 1762T 1764A mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology 29, 946–953.[CrossRef]
    [Google Scholar]
  3. Barnaba, V., Franco, A., Alberti, A., Balsano, C., Benvenuto, R. & Balsano, F. ( 1989; ). Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. J Immunol 143, 2650–2655.
    [Google Scholar]
  4. Beasley, R. P., Hwang, L. Y., Lin, C. C. & Chien, C. S. ( 1981; ). Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 318, 1129–1133.[CrossRef]
    [Google Scholar]
  5. Brechot, C., Gozuacik, D., Murakami, Y. & Paterlini-Brechot, P. ( 2000; ). Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Semin Cancer Biol 10, 211–231.[CrossRef]
    [Google Scholar]
  6. Chan, H. L., Hui, A. Y., Wong, M. L., Tse, A. M., Hung, L. C., Wong, V. W. & Sung, J. J. ( 2004; ). Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 53, 1494–1498.[CrossRef]
    [Google Scholar]
  7. Chen, C. H., Lee, C. M., Lu, S. N., Changchien, C. S., Eng, H. L., Huang, C. M., Wang, J. H., Hung, C. H. & Hu, T. H. ( 2005; ). Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan. J Clin Microbiol 43, 6000–6006.[CrossRef]
    [Google Scholar]
  8. Chen, B. F., Liu, C. J., Jow, G. M., Chen, P. J., Kao, J. H. & Chen, D. S. ( 2006a; ). High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130, 1153–1168.[CrossRef]
    [Google Scholar]
  9. Chen, C. J., Yang, H. I., Su, J., Jen, C. L., You, S. L., Lu, S. N., Huang, G. T. & Iloeje, U. H., REVEAL-HBV Study Group ( 2006b; ). Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295, 65–73.[CrossRef]
    [Google Scholar]
  10. Chen, G., Lin, W., Shen, F., Iloeje, U. H., London, W. T. & Evans, A. A. ( 2006c; ). Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol 101, 1797–1803.[CrossRef]
    [Google Scholar]
  11. Chen, C. H., Hung, C. H., Lee, C. M., Hu, T. H., Wang, J. H., Wang, J. C., Lu, S. N. & Changchien, C. S. ( 2007; ). Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology 133, 1466–1474.[CrossRef]
    [Google Scholar]
  12. Chisari, F. V. & Ferrari, C. ( 1995; ). Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13, 29–60.[CrossRef]
    [Google Scholar]
  13. Choi, M. S., Kim, D. Y., Lee, D. H., Lee, J. H., Koh, K. C., Paik, S. W., Rhee, J. C. & Yoo, B. C. ( 2007; ). Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J Viral Hepat 14, 161–168.[CrossRef]
    [Google Scholar]
  14. Fan, Y. F., Lu, C. C., Chang, Y. C., Chang, T. T., Lin, P. W., Lei, H. Y. & Su, I. J. ( 2000; ). Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection. J Gastroenterol Hepatol 15, 519–528.[CrossRef]
    [Google Scholar]
  15. Fan, Y. F., Lu, C. C., Chen, W. C., Yao, W. J., Wang, H. C., Chang, T. T., Lei, H. Y., Shiau, A. L. & Su, I. J. ( 2001; ). Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 33, 277–286.[CrossRef]
    [Google Scholar]
  16. Fang, Z. L., Ling, R., Wang, S. S., Nong, J., Huang, C. S. & Harrison, T. J. ( 1998; ). HBV core promoter mutations prevail in patients with hepatocellular carcinoma from Guangxi, China. J Med Virol 56, 18–24.[CrossRef]
    [Google Scholar]
  17. Fang, Z. L., Yang, J. Y., Ge, X. M., Zhuang, H., Gong, J., Li, R. C., Ling, R. & Harrison, T. J. ( 2002; ). Core promoter mutations (A1762T and G1764A) and viral genotype in chronic hepatitis B and hepatocellular carcinoma in Guangxi, China. J Med Virol 68, 33–40.[CrossRef]
    [Google Scholar]
  18. Fang, Z. L., Sabin, C. A., Dong, B. Q., Ge, L. Y., Wei, S. C., Chen, Q. Y., Fang, K. X., Yang, J. Y., Wang, X. Y. & Harrison, T. J. ( 2008; ). HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: A prospective study. Am J Gastroenterol 103, 2254–2262.[CrossRef]
    [Google Scholar]
  19. Gao, Z. Y., Li, T., Wang, J., Du, J. M., Li, Y. J., Li, J., Lu, F. M. & Zhuang, H. ( 2007; ). Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma. J Gastroenterol 42, 761–768.[CrossRef]
    [Google Scholar]
  20. Gunther, S., Li, B. C., Miska, S., Kruger, D. H., Meisel, H. & Will, H. ( 1995; ). A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 69, 5437–5444.
    [Google Scholar]
  21. Hannoun, C., Norder, H. & Lindh, M. ( 2000; ). An aberrant genotype revealed in recombinant hepatitis B virus strains from Vietnam. J Gen Virol 81, 2267–2272.
    [Google Scholar]
  22. Hsia, C., Yuwen, H. & Tabor, E. ( 1996; ). Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma. Lancet 348, 625–626.
    [Google Scholar]
  23. Hsieh, Y. H., Su, I. J., Wang, H. C., Chang, W. W., Lei, H. Y., Lai, M. D., Chang, W. T. & Huang, W. Y. ( 2004; ). Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25, 2023–2032.[CrossRef]
    [Google Scholar]
  24. Huy, T. T. T., Ushijima, H., Win, K. M., Luengrojanakul, P., Shrestha, P. K., Zhong, Z. H., Smirnov, A. V., Taltavull, T. C., Sata, T. & Abe, K. ( 2003; ). High prevalence of hepatitis B virus pre-S mutant in countries where it is endemic and its relationship with genotype and chronicity. J Clin Microbiol 41, 5449–5455.[CrossRef]
    [Google Scholar]
  25. Kao, J. H. ( 2002; ). Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol 17, 643–650.[CrossRef]
    [Google Scholar]
  26. Kao, J. H., Chen, P. J., Lai, M. Y. & Chen, D. S. ( 2003; ). Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124, 327–334.[CrossRef]
    [Google Scholar]
  27. Kekule, A. S., Lauer, U., Meyer, M., Caselmann, W. H., Hofschneider, P. H. & Koshy, R. ( 1990; ). The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 343, 457–461.[CrossRef]
    [Google Scholar]
  28. Li, J., Buckwold, V. E., Hon, M. W. & Ou, J. H. ( 1999; ). Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation. J Virol 73, 1239–1244.
    [Google Scholar]
  29. Lin, C. L., Liu, C. H., Chen, W., Huang, W. L., Chen, P. J., Lai, M. Y., Chen, D. S. & Kao, J. H. ( 2007; ). Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol 22, 1098–1103.[CrossRef]
    [Google Scholar]
  30. Liu, C. J., Chen, B. F., Chen, P. J., Lai, M. Y., Huang, W. L., Kao, J. H. & Chen, D. S. ( 2006; ). Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case–control study. J Infect Dis 194, 594–599.[CrossRef]
    [Google Scholar]
  31. Monto, A. & Wright, T. L. ( 2001; ). The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 28, 441–449.[CrossRef]
    [Google Scholar]
  32. Myers, R., Clark, C., Khan, A., Kellam, P. & Tedder, R. ( 2006; ). Genotyping Hepatitis B virus from whole- and sub-genomic fragments using position-specific scoring matrices in hbv star. J Gen Virol 87, 1459–1464.[CrossRef]
    [Google Scholar]
  33. Okamoto, H., Tsuda, F., Sakugawa, H., Sastrosoewignjo, R. I., Imai, M., Miyakawa, Y. & Mayumi, M. ( 1988; ). Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69, 2575–2583.[CrossRef]
    [Google Scholar]
  34. Raimondo, G., Costantino, L., Caccamo, G., Pollicino, T., Squadrito, G., Cacciola, I. & Brancatelli, S. ( 2004; ). Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases. J Hepatol 40, 515–519.[CrossRef]
    [Google Scholar]
  35. Santantonio, T., Jung, M. C., Schneider, R., Fernholz, D., Milella, M., Monno, L., Pastore, G., Pape, G. R. & Will, H. ( 1992; ). Hepatitis B virus genomes that cannot synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy. Virology 188, 948–952.[CrossRef]
    [Google Scholar]
  36. Schaefer, S. ( 2007; ). Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13, 14–21.[CrossRef]
    [Google Scholar]
  37. Simmonds, P. & Midgley, S. ( 2005; ). Recombination in the genesis and evolution of hepatitis B virus genotypes. J Virol 79, 15467–15476.[CrossRef]
    [Google Scholar]
  38. Sugauchi, F., Ohno, T., Orito, E., Sakugawa, H., Ichida, T., Komatsu, M., Kuramitsu, T., Ueda, R., Miyakawa, Y. & Mizokami, M. ( 2003; ). Influence of hepatitis B virus genotypes on the development of PreS deletions and advanced liver disease. J Med Virol 70, 537–544.[CrossRef]
    [Google Scholar]
  39. Sumi, H., Yokosuka, O., Seki, N., Arai, M., Imazeki, F., Kurihara, T., Kanda, T., Fukai, K., Kato, M. & Saisho, H. ( 2003; ). Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 37, 19–26.[CrossRef]
    [Google Scholar]
  40. Tai, P. C., Suk, F. M., Gerlich, W. H., Neurath, A. R. & Shih, C. ( 2002; ). Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants. Virology 292, 44–58.[CrossRef]
    [Google Scholar]
  41. Tanaka, Y., Mukaide, M., Orito, E., Yuen, M. F., Ito, K., Kurbanov, F., Sugauchi, F., Asahina, Y., Izumi, N. & other authors ( 2006; ). Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 45, 646–653.[CrossRef]
    [Google Scholar]
  42. Tran, T. T., Trinh, T. N. & Abe, K. ( 2008; ). New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol 82, 5657–5663.[CrossRef]
    [Google Scholar]
  43. Wang, H. C., Chang, W. T., Chang, W. W., Wu, H. C., Huang, W. Y., Lei, H. Y., Lai, M. D., Fausto, N. & Su, I. J. ( 2005; ). Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes. Hepatology 41, 761–770.[CrossRef]
    [Google Scholar]
  44. Wang, M., Ding, J. J. & Liu, Y. H. ( 2007; ). A study in the Guizhou area on pre-S region mutations of hepatitis B virus. Zhonghua Gan Zang Bing Za Zhi 15, 98–102 (in Chinese).
    [Google Scholar]
  45. Yu, M. W., Yeh, S. H., Chen, P. J., Liaw, Y. F., Lin, C. L., Liu, C. J., Shih, W. L., Kao, J. H., Chen, D. S. & Chen, C. J. ( 2005; ). Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 97, 265–272.[CrossRef]
    [Google Scholar]
  46. Yuen, M. F., Tanaka, Y., Mizokami, M., Yuen, J. C. H., Wong, D. K. H., Yuan, H. J., Sum, S. M., Chan, A. O. O., Wong, B. C. Y. & Lai, C. L. ( 2004; ). Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study. Carcinogenesis 25, 1593–1598.[CrossRef]
    [Google Scholar]
  47. Yuen, M. F., Tanaka, Y., Shinkai, N., Poon, R. T., But, D. Y., Fong, D. Y., Fung, J., Wong, D. K., Yuen, J. C. & other authors ( 2008; ). Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. Gut 57, 98–102.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.2008/002824-0
Loading
/content/journal/jgv/10.1099/vir.0.2008/002824-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error